Cellectar Biosciences to Host Conference Call on May 12th to Discuss First Quarter 2015 Results and Provide Update on Development Programs May 5, 2015
Cellectar Biosciences Initiates Proof-of-Concept Trial of I-131-CLR1404 in Multiple Myeloma Apr 15, 2015
Cellectar Biosciences to Host Conference Call on March 24th to Discuss Fourth Quarter and Full Year 2014 Results and Provide Update on Development Progress Mar 17, 2015
Peer-Reviewed Glioma Surgery Study With Cellectar Biosciences Fluorescence Cancer-Targeting Agents Chosen for the Cover of Neurosurgery Jan 22, 2015
Cellectar Biosciences Granted Orphan Designation for I-131-CLR1404 for the Treatment of Multiple Myeloma Dec 4, 2014
Cellectar Biosciences Names Cameron Szakacs, Ph.D. Vice President of Clinical Development Nov 25, 2014
